File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Combined bortezomib and venetoclax targets the pro-survival functions of latent viral proteins in Epstein-Barr virus-driven lymphoproliferative diseases

TitleCombined bortezomib and venetoclax targets the pro-survival functions of latent viral proteins in Epstein-Barr virus-driven lymphoproliferative diseases
Authors
Chiang, ATam, KAu-Yeung, R
Issue Date20-Oct-2022
Persistent Identifierhttp://hdl.handle.net/10722/333881

 

DC FieldValueLanguage
dc.contributor.authorChiang, A-
dc.contributor.authorTam, K-
dc.contributor.authorAu-Yeung, R-
dc.date.accessioned2023-10-06T08:39:52Z-
dc.date.available2023-10-06T08:39:52Z-
dc.date.issued2022-10-20-
dc.identifier.urihttp://hdl.handle.net/10722/333881-
dc.languageeng-
dc.relation.ispartof7th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma (20/10/2022-23/10/2022, New York )-
dc.titleCombined bortezomib and venetoclax targets the pro-survival functions of latent viral proteins in Epstein-Barr virus-driven lymphoproliferative diseases-
dc.typeConference_Paper-
dc.identifier.doi10.1016/S0145-2126(22)00228-4-
dc.identifier.volume121-
dc.identifier.spageS25-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats